Table 1

Rapid effects of corticosterone on neuronal functioning in the hypothalamus, hippocampus, amygdala and prefrontal cortex

Effect Receptor Conc Area Delay in onset Preparation Signalling pathways Remarks References
Hypothalamus
 mEPSC freq ↓ Other 100 nM PVN and SON 5 min Rat, ex vivo Gαs, cAMP-PKA, ECB, CB1 (1), (3), NR [1–4]
 mIPSC freq ↑ Other 1 μM PVN and SON 5 min Rat, ex vivo Gβγ, NO release (1), (3) [2,4]
 eEPSC freq ↓, eIPSC amplitude ↑ Unknown 1 μM SON 7 min Rat, ex vivo [4]
 2-AG and AEA levels ↑ Unknown 1 μM Hypothalamus 10 min Rat, ex vivo PKA [3,4]
Hippocampus
 mEPSC freq ↑ mMR 10 nM CA1 & DG 5 min Mouse, ex vivo ERK1/2 (1), (2), (3), (4), R [5–8]
 IA current ↓ MR 100 nM CA1 5 min Mouse, ex vivo G-proteins (3), R [6]
 AMPAR mobility ↑ mMR 50 nM CA1 2 min Rat, embryonic culture (1), (3) [9]
 mIPSC freq ↑ MR 30 nM Ventral CA1 Not known Rat, ex vivo (3) [10]
 MR at membrane mMR Hippocampus Mouse, embryonic culture IFM, WB on synaptosomal fractions [7]
 Spine density ↑ mGR 100 nM CA1 60 min Rat, ex vivo (2), (3) [11]
 GR at membrane mGR Hippocampus Mouse, ex vivo WB on synaptosomal fractions [11]
 Aspartate and glutamate levels ↑ Other 600 ng/ml local Hippocampus 20 min Rat, in vivo (2), (3) [12]
 NMDA-dependent neurotoxicity ↑ Other 10 nM Hippocampus 15 min (+24 h) Rat, postnatal culture ERK1/2, NR2A (1), (3) [13]
 LTP induction ↑ Other 100 nM CA1 10 min Mouse, ex vivo (3) [14]
 sIPSC freq ↑ Other 25 nM CA1 5 min Rat, ex vivo G-proteins, NO (1), (3) [15]
 NMDA-dependent current ↓ Not GR 100 nM Hippocampus Seconds Rat, postnatal culture cAMP-PKA (1), (3), R [16]
 NMDA-dependent current prolonged Not GR 1 μM Hippocampus Seconds Rat, postnatal culture (1), (3), R [17]
 AEA levels ↑ Unknown 3 mg/kg s.c. Hippocampus 10 min Rat, in vivo [18]
 NMDA-dependent current ↓ Unknown 400 nM CA1 Seconds Mouse, ex vivo (1) [19]
 Ca2+-currents ↓ Unknown 10 pM CA1 4 min Guinea pig, ex vivo G-proteins, PKC [20]
Amygdala
 GR in membrane mGR BLA Mouse EM [21]
 MR in membrane mMR BLA Mouse EM [22]
 mEPSC freq ↑ MmR 100 nM BLA 15 min Mouse, ex vivo (1), (2), (3), (4), NR [23]
 mEPSC freq ↓ mGR 100 nM BLA 15 min Mouse, ex vivo CB1 (1), (2), (3), (4), NR only after stress [23]
 AEA levels ↑ Unknown 3 mg/kg s.c. Amygdala 10 min Rat, in vivo [18]
Prefrontal cortex
 Glutamate uptake ↑ Unknown 10 nM Frontal cortex 5 min Rat, cultured synaptosomes G-proteins No nuclei present [24]
 Calmodulin dynamics ↑ Unknown 30 nM Cortex 15 min Rat, cultered synaptosomes No nuclei present [25]
  • (1), Use of cort-BSA or dex-BSA; (2), not prevented by protein inhibitor; (3), use of MR and GR antagonists; (4), use of MR- and GR-knockout mice; ‘unknown’, receptor was not examined; ‘other’, not the MR or GR; eIPSC/EPSC, evoked IPSC/EPSC; AEA, anandimide; 2-AG, 2-arachidonoylglycerol; sIPSC, spontaneous IPSC; mMR/mGR, membrane-associated MR/GR; ECB, endocannabinoids; CB1, cannabinoid receptor type 1; NO, nitric oxide; NR2A, NMDA receptor 2A subunit; PKC, protein kinase C; WB, western blot; IFM, immunofluorescent microscopy; EM, electron microscopy; NR, non-reversible; R, reversible. References: [1], Di et al. 2003; [2], Di et al. 2005; [3], Malcher-Lopes et al. 2006; [4], Di et al. 2009; [5], Karst et al. 2005; [6], Olijslagers et al. 2008; [7], Qiu et al. 2010; [8], Pasricha et al. 2011; [9], Groc et al. 2008; [10], Maggio & Segal 2009; [11], Komatsuzaki et al. 2005; [12], Venero & Borrell 1999; [13], Xiao et al. 2010; [14], Wiegert et al. 2006; [15], Hu et al. 2010; [16], Liu et al. 2007; [17], Takahashi et al. 2002; [18], Hill et al. 2010; [19], Sato et al. 2004; [20], Ffrench-Mullen 1995; [21], Johnson et al. 2005; [22], Prager et al. 2010; [23], Karst et al. 2010; [24], Zhu et al. 1998; [25], Sze & Iqbal 1994.

This Article

  1. J Endocrinol vol. 209 no. 2 153-167